Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "DNA replication and damage response pathways" refers to a collection of molecular mechanisms that maintain genome integrity by ensuring accurate duplication of genetic material and repairing various forms of DNA damage. The **DNA damage response (DDR)** encompasses several distinct repair processes, including homologous recombination, non-homologous end joining, alternative end joining, nucleotide excision repair, mismatch repair, and base excision repair. These pathways involve sensors that detect specific types of DNA lesions—such as single-stranded breaks or double-stranded breaks—and recruit transducer kinases like ATM or ATR to activate downstream effectors such as p53 or BRCA1/2. The coordinated action of these proteins is essential for cell survival and prevention of mutations that can lead to diseases such as cancer[1]. **Note:** This entry does not refer to a single molecule or receptor but rather a group of interconnected cellular processes involving many different proteins. Therefore, it is not considered a canonical therapeutic target itself but rather an umbrella term for multiple targets within these pathways[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA replication and damage response pathway (DDR (for "DNA damage response"; no standard abbreviation for the full pathway set)).